Chemodex

Glycochenodeoxycholic acid . sodium salt

CHF 150.00
In stock
CDX-G0033-M500500 mgCHF 150.00
CDX-G0033-G0011 gCHF 264.00
More Information
Product Details
Synonyms Sodium glycochenodeoxycholate; GCDCA; NSC 681056; Chenylglycine sodium; N-(3α,7α-Dihydroxy-24-oxocholan-24-yl)glycine sodium salt
Product Type Chemical
Properties
Formula C26H42NNaO5
MW 471.61
CAS 16564-43-5
Source/Host Chemicals Synthetic.
Purity Chemicals ≥97% (HPLC)
Appearance White to off-white powder.
Solubility Slightly soluble in DMSO, ethanol or methanol (10mg/ml) and in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key AAYACJGHNRIFCT-YRJJIGPTSA-M
Smiles [H][C@]1([C@@H](CCC(NCC(O[Na])=O)=O)C)CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +20°C
Handling Advice Keep cool and dry.
Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Glycochenodeoxycholic acid (GCDCA) is a bile salt formed in the liver that acts as a biosurfactant to solubilize lipids for absorption and is itself absorbed. GCDCA functions as a choleretic, increasing the volume of bile secreted from the liver, and a cholagogue, promoting the discharge of bile from the digestive system. GCDCA has been used to demonstrate a role for bile acids in promoting colorectal carcinogenesis and to inhibit calcium hydroxyapatite precipitation to study the pathogenesis of black pigment gallstones. This product has also been shown to induce apoptosis in isolated hepatocytes via modulation of PKC activity. This compound is used as an anionic detergent to solubilize lipids and as a chiral reagent.

Product References

(1) S. Barnes, et al.; J. Lipid Res. 20, 952 (1979) | (2) S.M. Qiu, et al.; J. Clin. Invest. 88, 1265 (1991) | (3) B. Gonzalez, et al.; Mol. Cell. Biochem. 207, 19 (2000) | (4) M. Iwata, et al.; Hepatol. Res. 25, 329 (2003) | (5) S. Ishizuka, et al.; Biomed. Res. 33, 159 (2012)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.